ASO Author Reflections: Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes

Yoshihiro Miyasaka; Masafumi Nakamura

doi:10.1245/s10434-019-07857-z

ASO Author Reflections: Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes

Yoshihiro Miyasaka
, Masafumi Nakamura

外科学

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

2 被引用数 (Scopus)

本文言語	英語
ページ（範囲）	739-740
ページ数	2
ジャーナル	Annals of Surgical Oncology
巻	26
DOI	https://doi.org/10.1245/s10434-019-07857-z
出版ステータス	出版済み - 12月 1 2019

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

SDG 3 すべての人に健康と福祉を

!!!All Science Journal Classification (ASJC) codes

外科
腫瘍学

文献へのアクセス

10.1245/s10434-019-07857-z

他のファイルとリンク

引用スタイル

@article{1d4dd9082ca542cf9a67ed7e5a0f061c,

title = "ASO Author Reflections: Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes",

author = "Yoshihiro Miyasaka and Masafumi Nakamura",

year = "2019",

month = dec,

day = "1",

doi = "10.1245/s10434-019-07857-z",

language = "English",

volume = "26",

pages = "739--740",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - ASO Author Reflections

T2 - Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes

AU - Miyasaka, Yoshihiro

AU - Nakamura, Masafumi

PY - 2019/12/1

Y1 - 2019/12/1

UR - https://www.scopus.com/pages/publications/85075792406

UR - https://www.scopus.com/pages/publications/85075792406#tab=citedBy

U2 - 10.1245/s10434-019-07857-z

DO - 10.1245/s10434-019-07857-z

M3 - Comment/debate

C2 - 31538287

AN - SCOPUS:85075792406

SN - 1068-9265

VL - 26

SP - 739

EP - 740

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

ER -